MeadowBrook Investment Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-300
Closed -$4.48K 298
2024
Q4
$4.48K Hold
300
﹤0.01% 283
2024
Q3
$5.74K Hold
300
0.01% 269
2024
Q2
$6.21K Hold
300
0.01% 257
2024
Q1
$5.64K Hold
300
0.01% 269
2023
Q4
$4.33K Buy
+300
New +$4.08K ﹤0.01% 286

Other funds holding OGN

MeadowBrook Investment Advisors's OGN Position: Q1 2025 in Review

MeadowBrook Investment Advisors sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 300 shares — an estimated $4.48K sold.

MeadowBrook Investment Advisors first reported a position in OGN in Q4 2023 and held it in 5 quarters. The position peaked at $6.21K in Q2 2024. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • MeadowBrook Investment Advisors reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • MeadowBrook Investment Advisors sold 300 Organon & Co shares in Q1 2025, an estimated $4.48K.
  • MeadowBrook Investment Advisors first reported a position in Organon & Co in Q4 2023 and held it in 5 quarters.
  • MeadowBrook Investment Advisors's Organon & Co position peaked at $6.21K in Q2 2024.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on MeadowBrook Investment Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.